Jafar Al-Mondhiry, MD
Jafar Al-Mondhiry, MD
Specialty
Years of Experience
9
Gender
Male
Jafar Al-Mondhiry, MD
Jafar Al-Mondhiry, MD
Medical Oncology,
Hematology,
Internal Medicine
Locations
8081 Innovation Park Dr
Level 5 - Chesapeake Clinic
Fairfax, VA 22031-4867
Phone
Fax
571-472-1188
44045 Riverside Pkwy
108
Leesburg, VA 20176
Phone
Fax
703-858-8603
About Jafar Al-Mondhiry, MD
Dr. Jafar Al-Mondhiry is a specialty care physician board certified in medical oncology, hematology and internal medicine at Inova Health System. He joined Inova in 2022 and has been practicing since 2015.
Prior to joining Inova, Dr. Al-Mondhiry worked as an Assistant Professor of Clinical Medicine for the University of Southern California Norris Comprehensive Cancer Center at the University of Southern California Keck School of Medicine in Los Angeles, CA.
Outside the office, Dr. Al-Mondhiry enjoys running, writing, biking, snowboarding, hiking, practicing meditation and yoga, and listening to live music.
Awards/Associations
-
American College of Physicians
-
American Society for Bioethics and Humanities
-
American Society of Clinical Oncology
-
American Society of Hematology
-
Iraqi Medical Scientist Association
-
Gold Humanism Honor Society
Medical School
New York University School of Medicine
Residencies
New York University Grossman School of Medicine
Training Specialty: Internal Medicine
7/1/2015 - 6/30/2018
Training Specialty: Internal Medicine
7/1/2015 - 6/30/2018
Fellowships
UCLA David Geffen School of Medicine
Training Specialty: Hematology/Oncology
9/1/2018 - 8/31/2021
Training Specialty: Hematology/Oncology
9/1/2018 - 8/31/2021
Hospital Affiliations
Patient Reviews
About Patient Comments
The Patient Rating score is an average of all responses to physician related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are gathered from our Press Ganey Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.